Filing Details
- Accession Number:
- 0001209191-21-026823
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-15 16:15:00
- Reporting Period:
- 2021-04-13
- Accepted Time:
- 2021-04-15 16:15:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1637715 | Reneo Pharmaceuticals Inc. | RPHM | Pharmaceutical Preparations (2834) | 472309515 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1784138 | Bali Muralidhar | C/O Reneo Pharmaceuticals, Inc. 12230 El Camino Real, Suite 230 San Diego CA 92130 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-04-13 | 1,658,226 | $0.00 | 1,658,226 | No | 4 | C | Indirect | By Abingworth Bioventures 8 LP |
| Common Stock | Acquisiton | 2021-04-13 | 200,000 | $15.00 | 1,858,226 | No | 4 | P | Indirect | By Abingworth Bioventures 8 LP |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | By Abingworth Bioventures 8 LP |
| No | 4 | P | Indirect | By Abingworth Bioventures 8 LP |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series B Preferred Stock | Disposition | 2021-04-13 | 7,420,232 | $0.00 | 1,658,226 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect |
Footnotes
- All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering, for no additional consideration at a rate of 1 share of Common Stock for each 4.4748 shares of Preferred Stock. The Preferred Stock had no expiration date.
- See Exhibit 99.1
- The shares were purchased in the Issuer's initial public offering.
Billionaire Hedge Funds
